The Breast Cancer Research Foundation has announced grants totaling $59.5 million in support of research at academic and medical institutions in fifteen countries.
Representing BCRF's largest funding commitment to date, the grants will support the work of two hundred and seventy-five scientists, with more than $18 million supporting research on metastatic (Stage IV) breast cancer, including efforts to understand why and how cancer cells spread, the development of new treatments for the disease in its advanced stages, and studies aimed at discovering biomarkers that can predict which breast cancers are more likely to spread.
The organization also awarded grants in support of efforts to integrate novel mathematical methods with cancer biology, with the aim of studying the evolution of cancer, treatment response, and an individual's risk of treatment-related side effects. In partnership with the Jayne Koskinas Ted Giovanis Foundation for Health and Policy, BCRF also is funding three collaborations designed to provide new insights into tumor growth and metastasis and the mechanisms of drug resistance.
"We've seen the impact of research — mortality rates have decreased by 38 percent over the last twenty-five years," said BCRF president and CEO Myra Biblowit. “However, more than forty thousand women and men continue to die from the disease each year. BCRF remains dedicated to research until the numbers of deaths from breast cancer is zero. Research is the only path toward achieving that goal."
For more information on the 2017-18 grant recipients, see the BCRF website.